bf/NASDAQ:GLMD_icon.jpeg

COM:GALMEDPHARMA

Galmed Pharmaceuticals

  • Stock

1.28

−1.54%

−0.70

USD last updated 25/07 01:50:18

Last Close

1.98

24/07 22:31

Market Cap

1.82M

Beta: -

Volume Today

371.99K

Avg: -

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The com...Show More